Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins: the next anti-endotoxin.

Peter S Kruger1

  • 1Intensive Care Unit, Princess Alexandra Hospital, Brisbane, QLD, Australia. peter_kruger@health.qld.gov.au

Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|August 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between enteral carboxymethyllysine intake and daily glycemic variability in critically ill adults: A retrospective cohort study.

JPEN. Journal of parenteral and enteral nutrition·2025
Same author

Interference by piperacillin/tazobactam in the measurement of creatinine with the Jaffe method and of total protein with the biuret method.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2023
Same author

Simvastatin in Critically Ill Patients with Covid-19.

The New England journal of medicine·2023
Same author

The feasibility of using mouthpiece ventilation in the intensive care unit for post-extubation breathing support after acute tetraplegia.

Spinal cord·2023
Same author

Updated guideline on equipment to manage difficult airways: Australian and New Zealand College of Anaesthetists.

Anaesthesia and intensive care·2022
Same author

The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial.

American journal of respiratory and critical care medicine·2022
Same journal

A pragmatic risk-stratified framework for using large language models in intensive care medicine: A narrative review.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same journal

The cost analysis of remifentanil and fentanyl for analgosedation in mechanically ventilated patients in intensive care: Post hoc analysis of an open-labelled pilot randomised controlled study.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same journal

Analgesia and sedation practice in children in intensive care in Australia and New Zealand: A survey.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same journal

Evaluation of the clinical impact of different telemedicine practices in intensive care units: A stepped-wedge cluster randomized clinical trial (TELESCOPE 2): Study protocol.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same journal

Vasopressors or fluids for initial resuscitation in septic shock: A matter of clinical judgement.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same journal

Sodium bicarbonate in critical illness: Correcting acidaemia without changing outcomes?

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
See all related articles

Statins, cholesterol-lowering drugs, may reduce mortality in sepsis patients. Further research is needed to explore their anti-inflammatory benefits and potential use in critical care, despite current concerns about side effects.

Area of Science:

  • Pharmacology
  • Critical Care Medicine
  • Immunology

Background:

  • Sepsis remains a significant cause of illness and death.
  • Statins are widely used cholesterol-lowering medications, with increasing hospital admission use.
  • Current guidelines often advise stopping statins in acutely ill patients due to potential side effects.

Purpose of the Study:

  • To review evidence suggesting statins may reduce sepsis mortality.
  • To explore the non-lipid-lowering, anti-inflammatory, and immunomodulatory effects of statins.
  • To discuss the current role and future therapeutic potential of statins in sepsis management.

Main Methods:

  • Review of observational studies and basic science research on statins and sepsis.
  • Discussion of the pharmacological mechanisms of statins beyond lipid reduction.

Related Experiment Videos

  • Analysis of existing literature on statin use in critically ill patients.

    • Main Results:

    • Emerging evidence suggests a potential association between statin use and reduced sepsis mortality.
    • Statins possess anti-inflammatory and immunomodulatory properties independent of cholesterol lowering.
    • Concerns regarding side effects in acute illness may be limiting their use.

    Conclusions:

    • Statins may offer benefits in sepsis beyond lipid management, including anti-inflammatory effects.
    • Reappraisal of statin therapy indications in critically ill patients is warranted.
    • Investigating statins for sepsis could yield significant cost-benefit advantages due to their low cost.